Market brief
Baltic–German Biotech Supply Chain 2026: Manufacturing + Logistics
From Basel to Vilnius, biotech work now moves across four connected layers: large-scale biologics manufacturing in Switzerland and Germany (Lonza, Rentschler), discovery and development services in Poland (Selvita), biologics CDMO and research infrastructure in the Baltics (Northway, Biomapas), and GDP-certified pharmaceutical logistics tying them together (DHL Life Sciences & Healthcare, World Courier, Kuehne+Nagel Healthcare, plus Thermo Fisher Scientific and Avantor for reagents and tools). For a sponsor or procurement team, this is no longer “several companies in a region” — it’s a continuous supply chain where samples, APIs, reagents, and regulated shipments can be tracked node to node across the EU single market.
Summary
Key findings
Manufacturing depth sits in Switzerland and Germany (Lonza large-scale biologics, Rentschler clinical-to-commercial CDMO); development capacity is concentrated in Poland (Selvita medicinal chemistry, biology, DMPK); Baltic operators add flexible manufacturing (Northway) and clinical services (Biomapas).
GDP-certified pharmaceutical logistics is the connective tissue: DHL Life Sciences & Healthcare for healthcare warehousing and network reach, World Courier for temperature-controlled and GDP-critical movement (Vilnius vault), Kuehne+Nagel Healthcare for dedicated healthcare LTL.
The reagent, consumables, and tools layer (Thermo Fisher Scientific, Avantor / VWR) is what keeps production continuous — disruptions there show up as execution risk faster than most sourcing teams expect.
For cross-border biologics programmes, the practical routing is often Switzerland/Germany for large-scale manufacturing, Poland for development services, Baltics for supplementary manufacturing and clinical execution, and specialised logistics operators for GDP-governed movement between them.
Numbers
Quick numbers
Analysis
The western manufacturing depth
The western side of the chain starts with scale and validated systems. Lonza provides a benchmark for large-scale biologics manufacturing and process maturity in the DACH zone. Rentschler translates that into German CDMO execution with clinical-to-commercial continuity. These companies matter not only as names, but as reference points for how other regional pages should be interpreted.
Analysis
Polish development capacity
Selvita sits in a different part of the chain. It is not the same type of node as Lonza or Northway, and a good directory should preserve that distinction. Its strength lies in medicinal chemistry, discovery biology, DMPK, and development services that can plug into larger manufacturing systems upstream and downstream.
Analysis
Baltic manufacturing and logistics
Northway provides the eastern manufacturing anchor because it combines a visible leadership layer, live biologics manufacturing posture, and a broader Vilnius expansion story in one geography. It also sits closer to logistics and supply connectors across Lithuania and Poland, which makes the region easier to read as a working environment rather than a disconnected set of names.
Analysis
Why the logistics layer changes the picture
The logistics and supply layer is what turns the directory into something more useful than a company list. DHL nodes show how healthcare warehousing and network governance are scaling in Germany. World Courier documents GDP-critical movement and vault logic from Vilnius to Poland and Germany. Kuehne+Nagel adds healthcare road logistics and fulfilment infrastructure. Thermo Fisher Supply and Avantor / VWR show the reagent, consumables, and tools layer that supports production continuity.
What to watch
What to watch next
Expansion of Northway Biotech capacity at BIO CITY Vilnius
Rentschler and Lonza capacity expansion announcements
New GDP-certified cross-border lanes between Germany, Poland, and the Baltics
Thermo Fisher and Avantor supply-chain footprint changes in the region
Polish biotech cluster growth in Wroclaw and Krakow (Pure Biologics, Genomtec, Hemolens)
FAQ
Frequently asked questions
Which companies anchor the Baltic–German biotech supply chain?
Large-scale biologics manufacturing sits with Lonza (Switzerland) and Rentschler Biopharma (Germany). Development services concentrate at Selvita (Poland). The Baltics add flexible biologics CDMO capacity through Northway Biotech (Vilnius) and clinical services via Biomapas. GDP-certified logistics tie the network together through DHL Life Sciences & Healthcare, World Courier, and Kuehne+Nagel Healthcare.
Why is Vilnius part of the German biotech supply chain?
Vilnius sits inside the EU single market with live biologics CDMO capacity (Northway Biotech at BIO CITY), GDP-certified logistics presence (World Courier Baltics), and the Thermo Fisher Scientific supply chain already operating locally. For German biotech sponsors, Vilnius is a one-country-away nearshore option with lower operating cost and English-fluent talent.
How does Poland fit into this supply chain?
Poland provides discovery and development depth (Selvita medicinal chemistry, biology, DMPK), plus an expanding innovation belt in Wroclaw and Krakow (Pure Biologics, Genomtec, Hemolens). It is the natural discovery-plus-development node between German large-scale manufacturing and Baltic CDMO capacity.
Is the logistics layer really necessary to map?
Yes. GDP-certified pharmaceutical logistics and vault infrastructure are what turn a list of companies into a moving supply chain. DHL, World Courier, and Kuehne+Nagel are the operators that make samples, APIs, and regulated shipments traceable from Basel to Vilnius. Without this layer, the supply chain exists on paper but does not deliver.
Methodology note
Sources and interpretation
Sources: source-backed directory records, official facility and logistics disclosures, and editorial comparison of manufacturing depth, development capability, and supply-chain connectivity.
Disclaimer
Use limits
This brief is an analytical map of visible regional dynamics. It does not claim to represent the full European supply chain or every facility relevant to a given therapeutic program.
Primary sources
Source list
Related pages
Related directory records
Briefs
Continue through related topics.
A useful brief should help people move into related records, cities, categories, and methodology pages without falling back into generic template language.